Is HRT Safe for Women Now? The 2002 Study, Bioidentical Hormones, and What Changed
Episode Summary
Colin Renaud, PA-C and Dr. Sasha Rose, ND, two of the lead clinicians at Med Matrix, break down what women should actually understand about hormone replacement therapy and how the conversation has changed since the 2002 Women's Health Initiative study. Dr. Rose names the three things patients still misunderstand about that study, heart disease risk, breast cancer risk, and the hard rules against prescribing after age 65 or more than 10 years past menopause, and explains why it took nearly 25 years for the corrected picture to reach clinical practice. The conversation covers why HRT is not one thing: timing, dose, and route of administration matter, oral synthetic estrogen carries clot risk that transdermal estradiol does not, and today's bioidentical hormones are essentially identical to what the body makes. They walk through how hormones affect sleep, mood, muscle, metabolism, bone health, brain function, and blood sugar, why perimenopause symptoms can start around age 35, long before most providers consider hormones, and why estrogen deficiency is the number one reason women develop osteoporosis. The episode closes with the Med Matrix evaluation process, the full hormone panel (estradiol, progesterone, total and free testosterone, sex hormone binding globulin, cortisol, DHEA, full thyroid, fasting glucose and insulin), and a live Q&A on cyclic HRT, monitoring frequency, and starting HRT later in life for bone density.
Key Topics
- 1
The 2002 Women's Health Initiative study and what patients still misunderstand about it
- 2
Why it took nearly 25 years for corrected HRT evidence to reach clinical practice
- 3
Heart disease and breast cancer risk on HRT: what the data actually shows
- 4
Timing, dose, and route: why oral synthetic estrogen differs from transdermal estradiol
- 5
Bioidentical hormones versus the synthetic hormones used decades ago
- 6
How hormones affect sleep, mood, muscle, metabolism, bone health, and brain function
- 7
Perimenopause symptoms that can start around age 35, years before menopause
- 8
Estrogen deficiency as the number one reason women develop osteoporosis
- 9
Blood sugar and hormones: prediabetic A1C patterns in menopausal patients
- 10
Cyclic (sequential) HRT and how providers monitor and adjust doses over time
Quotable Moments
“it's taken 25 years basically almost 25 years for like kind of the truth to come out and to finally start to be implemented clinically”
“It prevented a generation of women from getting potentially really therapeutic medications.”
“We don't use synthetic hormones. We use bio identical. So, the hormones are essentially identical to what your body makes.”
“estrogen is the number one reason or a deficiency in estrogen is the number one reason why women get osteoporosis”
“menopause is actually just like a single day. It's 12 months after there's no bleeding, no period.”
Treatments Mentioned
FAQ
Hormone Health FAQ
It depends on the specifics, which is exactly what the old headlines missed. Dr. Sasha Rose explains that HRT is not one thing: the timing, the dose, the route of administration, and the individual woman's history and risk factors make all the difference. Oral synthetic estrogen can increase blood clot risk, while transdermal estradiol really does not. With the right route, appropriate dosing, and careful monitoring, Colin Renaud, PA-C notes that hormones become very safe and very manageable.
Dr. Sasha Rose names three things patients still misunderstand from that study: the risk of heart disease on HRT, the risk of breast cancer or recurrence, and the blanket rules that HRT should never be prescribed after age 65 or more than 10 years past menopause. Women were taken off hormones almost overnight, and it has taken nearly 25 years for the corrected interpretation to start being implemented clinically.
Colin Renaud, PA-C explains that the cancer fears trace back to an era when women were given synthetic hormones, often for only a short symptomatic window before being taken off. Med Matrix does not use synthetic hormones. Bioidentical hormones are essentially identical to what the body makes, and they are prescribed with individualized dosing, route selection, and ongoing monitoring.
Dr. Sasha Rose notes that even for a woman starting around age 74 or 75, there can still be gains in bone mineral density with appropriately dosed and administered estradiol, customized to her situation. Colin Renaud, PA-C adds that estrogen deficiency is the number one reason women get osteoporosis, because estrogen helps rebuild the bone matrix, so it is not too late for bone density benefits.
Colin Renaud, PA-C typically gives it about three months after starting before reassessing. Dr. Sasha Rose adds that adjusting is a normal part of the process, even the best HRT specialists nail the dosing about 50 percent of the time on the first try, so expect some tweaking. Once symptoms and blood work have stabilized, monitoring drops to about two to three times a year.
Much earlier than most people think. Dr. Sasha Rose explains that menopause itself is just a single day, 12 months after the last period, and the 10 to 15 years before that date, perimenopause, often carry the worst symptoms. Fluctuations in estrogen and drops in progesterone and testosterone can begin around age 35 or even younger, which is why fatigue, irritability, weight gain, and disrupted sleep are so often missed because of a woman's age.
Related Service
Learn More
Women's Health
Tired, gaining weight, not sleeping? Med Matrix tests 80+ biomarkers including full hormones, thyroid, and cortisol. Bioidentical HRT, perimenopause care, 60-min visits. 4.9 stars. $100 off.
